Irina Dralyuk, MD, discusses a wearable stethoscope for asthma monitoring in children

Cedars-Sinai Guerin Children’s has launched a new pediatric asthma monitoring program that uses a wearable stethoscope designed to detect early respiratory changes in children with asthma and support earlier clinical intervention.¹

The at-home monitoring device, called AeviceMD, was developed by Singapore-based Aevice Health in collaboration with Cedars-Sinai. The wearable technology enables clinicians and families to remotely monitor respiratory symptoms, including wheezing, respiratory rate, and heart rate, in real time.

According to the health system, approximately 4.5 million children in the United States have asthma, making it one of the most common chronic pediatric diseases. Asthma management often relies on intermittent clinic visits and caregiver-reported symptoms, which can make it difficult to identify worsening disease activity between appointments.

“I saw strong potential in this technology to support how we monitor and manage children with reactive airway issues like asthma outside of the clinical setting,” said Irina Dralyuk, MD, pediatric pulmonologist at Cedars-Sinai Guerin Children’s.

The device, approximately the size of a half-dollar coin, attaches to the chest using an adhesive patch and can record lung sounds for brief spot checks or continuous overnight monitoring. It is intended for children aged 3 years and older.

Can wearable devices detect worsening asthma symptoms earlier?

In an interview discussing the program and related research presented at the American Thoracic Society meeting, Dralyuk described a 12-week trial evaluating the device in pediatric patients with asthma. Families were asked to place the monitor on children nightly while researchers remotely tracked respiratory data.

“What we're trying to do is one, see if the device is able to pick up these sounds and let us know that the child is having asthma symptoms, but also see if it's predictive,” Dralyuk said. “The early numbers had shown that it was actually able to predict with fairly reasonable accuracy, about 66%, the likelihood of an impending wheeze based on vital sign variability.”

The device captures wheezing, which can serve as an early sign of worsening asthma. According to Dralyuk, the technology may help clinicians intervene before symptoms progress to severe exacerbations.

“So basically, the need is trying to intervene earlier and having some kind of information that we could base the intervention on,” Dralyuk said.

The wearable monitor may also provide families with objective information that is difficult to recognize without medical training.

“So basically it gives us actual scientific measurements of what's happening in the child's body to help guide the parent and then the physician, if need be,” Dralyuk said.

Could wearable asthma monitoring reduce hospitalizations?

Clinicians at Cedars-Sinai hope remote respiratory monitoring may help reduce emergency department visits, hospitalizations, and systemic corticosteroid exposure among pediatric patients with asthma.

“What we’re trying to do is prevent exacerbations, reduce hospitalizations and emergency department visits, and limit the need for interventions such as systemic steroid use to control asthma symptoms,” Dralyuk said in the announcement. “Intervening early could decrease chronic inflammation and improve lung function and health over time.”

Dralyuk added that the technology could also support treatment optimization by helping clinicians identify persistent nighttime symptoms and earlier worsening of disease control than traditional follow-up schedules allow.

“To me, this is really going to improve our ability to prevent emergency room visits, urgent care visits, hospitalizations, these big, horrible things that can happen with asthma,” Dralyuk said.

The collaboration between Cedars-Sinai and Aevice Health began in 2022 and included clinical guidance from physicians at Guerin Children’s. In 2023, AeviceMD received clearance from the US Food and Drug Administration.²

“We built AeviceMD to make this kind of continuous symptom visibility possible,” said Adrian Ang, CEO of Aevice Health. “Having our technology deployed at a large, world-class health system like Cedars-Sinai validates our belief that there is a critical, unmet patient need.”

Nirdesh K. Gupta, PhD, managing partner of Cedars-Sinai Intellectual Property Company, said the collaboration demonstrates how health systems and industry partnerships may help advance pediatric care technologies into clinical practice.

“This collaboration demonstrates the importance of providing clinical and operational support to help advance a company’s promising technology toward real-world patient benefit,” Gupta said.

References

1. Cedars Sinai. At-Home Monitoring Device Could Improve Asthma Care for Pediatric Patients. Cedars Sinai. May 14, 2026. Accessed May 28, 2026. https://www.cedars-sinai.org/newsroom/at-home-monitoring-device-could-improve-asthma-care-for-pediatric-patients/

2. Aevice Health. Aevice Health Secures US FDA Clearance for Remote Respiratory Monitoring Platform enabled by Smart Wearable Stethoscope. Aevice Health. July 20, 2023. Accessed May 28, 2026. https://www.aevice.com/sg/press/aevice-health-secures-us-fda-clearance